Welcome to Library
Annual Reports
RMRIMS News Bulletine
 
Publications List of Dr. Niyamat Ali Siddiqui

 

33

Rabi Das VN, Siddiqui NA, Pal B, Lal CS, Verma N, Kumar A, Verma RB, Kumar D, Das P and Pandey K. To evaluate efficacy and safety of amphotericin B in two different doses in the treatment of post kala-azar dermal leishmaniasis (PKDL). PLoS One. 2017 Mar 29;12(3):e0174497. doi: 10.1371/journal.pone.0174497. eCollection 2017.

32

Pandey K, Pal B, Das VN, Murti K, Lal CS, Verma N, Bimal S, Ali V, Verma RB, Topno RK, Siddiqi NA and Das P. Safety and efficacy of a combination of Paromomycin and Miltefosine for two versus three courses in patients with Post Kala-Azar Dermal Leishmaniasis (PKDL) - an observational pilot Study. Br J Dermatol. 2017; 177(2):557-559. doi: 10.1111/bjd.15119. Epub 2017 Jul 2.

31

Pal B, Murti K, Siddiqui NA, Das P, Lal CS, Babu R, Rastogi MK and Pandey K. Assessment of quality of life in patients with post kalaazar dermal leishmaniasis. Health Qual Life Outcomes. 2017; 15(1): 148. doi: 10.1186/s12955-017-0720-y.

30

Mishra A, Nizammuddin S, Basu Mallick C, Singh S, Prakash S, Siddiqui NA, Rai N, Carlus SJ, Sudhakar DV, Tripathi VP, Möls M, Kim-Howard X, Dewangan H, Mishra A, Reddy AG, Roy B, Pandey K, Chaubey G, Das P, Nath SK, Singh L and Thangaraj K. Genotype-phenotype study of Middle Gangetic Plain in India reveals association of rs2470102 with skin pigmentation. J Invest Dermatol. 2017; 137(3):670-677. doi: 10.1016/j.jid.2016.10.043. (Epub 2016 Nov 17).

29

Scott J, Das VN and Siddiqui NA. Community-based Detection of Post Kala-azar Dermal Leishmaniasis (PKDL) and its Risk-Factors in an Endemic Region of Bihar, India. J Trop Dis 2016; 4:219. doi:10.4172/2329-891X.1000219

 

28

Siddiqui NA, Rabidas VN, Sinha SK, Verma RB, Pandey K, Singh VP, Ranjan A, Topno RK, Lal CS, Kumar V, Sahoo GC, Sridhar S, Pandey A and Das P. Snowball Vs. House-to-House Technique for Measuring Annual Incidence of Kala-azar in the Higher Endemic Blocks of Bihar, India: A Comparison. PLoS Negl Trop Dis. 2016; 10(9): e0004970. doi: 10.1371/journal.pntd.0004970.

27

Das VN, Pandey RN, Siddiqui NA, Chapman LA, Kumar V, Pandey K, Matlashewski G and Das P. Longitudinal Study of Transmission in Households with Visceral Leishmaniasis, Asymptomatic Infections and PKDL in Highly Endemic Villages in Bihar, India. PLoS Negl Trop Dis. 2016; 10(12): e0005196. doi: 10.1371/journal.pntd.0005196.

26

Das VN, Pandey RN, Kumar V, Pandey K, Siddiqui NA, Verma RB, Matlashewski G and Das P. Repeated training of accredited social health activists (ASHAs) for improved detection of visceral leishmaniasis cases in Bihar, India. Pathog Glob Health. 2016; 110(1): 33-35. doi: 10.1080/20477724.2016.1156902.

25

Pandey K, Ravidas V, Siddiqui NA, Sinha SK, Verma RB, Singh TP, Dhariwal AC, Das Gupta RK and Das P. Pharmacovigilance of Miltefosine in Treatment of Visceral Leishmaniasis in Endemic Areas of Bihar, India. Am J Trop Med Hyg. 2016; 95(5): 1100-1105.

24

Lal CS, Verma RB, Verma N, Siddiqui NA, Rabidas VN, Pandey K, Singh D, Kumar S, Paswan RK, Kumari A, Sinha P and Das P. Hypertriglyceridemia: a possible diagnostic marker of disease severity in visceral leishmaniasis. Infection. 2016; 44(1): 39-45. doi: 10.1007/s15010-015-0811-9. (Epub 2015 Jul 10).

23

Naznin E, Kroeger A, Siddiqui NA, Sundar S, Malaviya P, Mondal D, Huda MM, Das P, Karki P, Banjara MR, Dreesch N and Gedik G. Human resource assessment for scaling up VL active case detection in Bangladesh, India and Nepal. Trop Med Int Health. 2013; 18(6): 734-742. doi: 10.1111/tmi.12124. (Epub 2013 May 8).

22

Bhunia GS, Chatterjee N,  Kumar V, Siddiqui NA, Mandal R, Das P and Kesari S. Delimitation of kala-azar risk areas in the district of Vaishali in Bihar (India) using a geo-environmental approach. Mem Inst Oswaldo Cruz, Rio de Janeiro. 2012; 107(5): 609-620.

21

Banjara MR, Hirve S, Siddiqui NA, Kumar N, Kansal S, Huda MM, Das P, Rijal S, Gurung CK, Malaviya P, Arana B, Kroeger A and Mondal D. Visceral Leishmaniasis clinical management in endemic districts of India, Nepal and Bangladesh. Journal of Tropical Medicine, 2012; 2012: 126093. (Epub 2012 May 9).

20

Das VNR, Ranjan A, Pandey K, Singh D, Verma N, Das S, Lal CS, Sinha NK, Verma RB, Siddiqui NA, and Das P. Short Report: Clinico-Epidemiologic Profile of a Cohort of Post–Kala-Azar Dermal Leishmaniasis Patients in Bihar, India. Am. J. Trop. Med. Hyg., 2012; 86(6): 959–961.

19

Pandey K, Das VN, Singh D, Das S, Lal CS, Verma N, Bimal S, Topno RK, Siddiqui NA, Verma RB, Sinha PK and Das P. Post-kala-azar dermal leishmaniasis in a patient treated with injectable paromomycin for visceral leishmaniasis in India. J Clin Microbiol. 2012; 50(4): 1478-1479. (Epub 2012 Jan 25).

18

Das VN, Siddiqui NA, Verma RB, Topno RK, Singh D, Das S, Ranjan A, Pandey K, Kumar N and Das P. Asymptomatic infection of visceral leishmaniasis in hyperendemic areas of Vaishali district, Bihar, India: a challenge to kala-azar elimination programmes. Trans R Soc Trop Med Hyg, 2011; 105(11): 661-666. (Epub 2011 Sep 25).

17

Kumar N, Singh SP, Mondal D, Joshi A, Das P, Sundar S, Kroeger A, Hirve S, Siddiqui NA and Boelaert M. How do health care providers deal with kala-azar in the Indian subcontinent?. Indian J Med Res, 2011; 134(3): 349-55.

15

Siddiqui NA, Kumar N, Ranjan A, Pandey K, Das VNR, Verma RB and Das P. Awareness about Kala-azar disease and related preventive attitudes and practices in a highly endemic rural area of India.  Southeast Asian journal of tropical medicine and public health, 2010; 41(1): 1-12.

14

Sarnoff R, Desai J, Desjeux P, Mittal A, Topno R, Siddiqui NA, Pandey A, Sur D and Das P. Visceral leishmaniasis supplement: the economic impact of visceral leishmaniasis on rural households in one endemic district of Bihar, India.  Trop Med Int Health. 2010 May 6. [Epub ahead of print]

13

Das P, Samuels S, Desjeux P, Mittal A, Topno R, Siddiqui NA, Sur D, Pandey A and Sarnoff R. Annual incidence of visceral leishmaniasis in an endemic area of Bihar, India. Tropical Medicine and International Health, 2010; 15(suppl. 2):1-8.

12

Mubayi A, Castillo-Chavez C, Chowell G, Kribs-Zaleta C, Ali Siddiqui N, Kumar N and Das P. Transmission dynamics and underreporting of Kala-azar in the Indian state of Bihar. Journal of Theoretical Biology, 2010; 262(1): 177-185.


11

Topno RK, Das VN, Ranjan A, Pandey K, Singh D, Kumar N, Siddiqui NA, Singh VP, Kesari S, Kumar N, Bimal S, Kumar AJ, Meena C, Kumar R and Das P. Asymptomatic infection with visceral leishmaniasis in a disease-endemic area in bihar, India. Am J Trop Med Hyg, 2010; 83(3): 502-506.

10

Das VN, Pandey K, Verma N, Lal CS, Bimal S, Topno RK, Singh D, Siddiqui NA, Verma RB and Das P. Development of Post Kala-Azar Dermal Leishmaniasis (PKDL) in Miltefosinetreated visceral leishmaniasis. American Journal of Tropical Medicine and Hygiene, 2009; 80(3): 336-338.


09

Das VN, Siddiqui NA, Pandey K, Singh VP, Topno RK, Singh D, Verma RB, Ranjan A, Sinha PK and Das P. A controlled, randomized nonblinded clinical trial to assess the effi cacy of  mphotericin B deoxycholate as compared to pentamidine for the treatment of antimony unresponsive visceral leishmaniasis cases in Bihar, India. Therapeutics and Clinical Risk Management, 2009; 5: 117–124.


08

Kumar N, Siddiqui NA, Verma RB and Das P. Knowledge About Sandflies in Relation to Public and Domestic Control Activities of Kala-azar in Rural Endemic Areas of Bihar. Journal of Communicable Diseases, 2009, 41(2): 121-128.

07

Pandey k, Sinha PK, Das VN, Nawin Kumar,.Bimal S, Verma RB, Verma N, Lal CS, Topno RK, Siddiqui NA, Singh D and Das P. Tuberous sclerosis with visceral leishmaniasis: a case report. Journal of Medical Case Reports, 2009; 3: 9027.


06

Topno RK, Pandey K, Das VN, Kumar N, Bimal S, Verma RB, Siddiqui NA, Singh D, Kumar R, Kumar P, Ranjan A, Das P and Sinha PK. Visceral Leishmaniasis in pregnancy – role of Amphotericin B. Ann. Trop. Med. & Parasitol, 2008; 102(3): 267-270.

05

Das VN, Siddiqui NA, Kumar N, Verma N, Verma RB, Dinesh DS, Kar SK and Das P . A pilot study on the status of lymphatic filariasis in a rural community of Bihar. J Commun Dis, 2006; 38(2): 169-75.


04

Das VN, Pandey K, Kumar N, Hassan SM, Bimal S, Lal CS, Siddiqui NA and Bhattacharya SK. Visceral leishmaniasis and tuberculosis in patients with HIV co-infection. Southeast Asian J Trop Med Public Health, 2006; 37(1): 18-21.


03

Kumar N, Siddiquiu NA, Verma RB, Rabidas VNR, Verma N and Kar SK . A pilot study on mother's knowledge and their perception about control, transmission and treatment of Lymphatic Filariasis in a rural community of Bihar. Journal of Parasitic Diseases, 2003; 27: 33-37.

02

Kumar N, Siddiqui NA, Verma R and Kar S.K. Women's perceptions on kala-azar. Journal of Parasitic Disease. 2002; 26: 38-41.

01

Das VN, Ranjan A, Sinha AN, Verma N, Lal CS, Gupta AK, Siddiqui NA and Kar SK. A randomized clinical trial of low dosage combination of pentamidine and allopurinol in the treatment of antimony unresponsive cases of visceral leishmaniasis. Journal of Association of Physician of India, 2001; 49: 609-613.